NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 214, Issue 6, Pages 1711-1724
Publisher
Rockefeller University Press
Online
2017-04-25
DOI
10.1084/jem.20161707
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inflammasomes and Cancer
- (2017) Rajendra Karki et al. Cancer Immunology Research
- CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma
- (2016) Colin W. Steele et al. CANCER CELL
- γδ T Cells Support Pancreatic Oncogenesis by Restraining αβ T Cell Activation
- (2016) Donnele Daley et al. CELL
- Radiation Therapy Induces Macrophages to Suppress T-Cell Responses Against Pancreatic Tumors in Mice
- (2016) Lena Seifert et al. GASTROENTEROLOGY
- Mincle suppresses Toll-like receptor 4 activation
- (2016) Stephanie H. Greco et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression
- (2016) Lena Seifert et al. NATURE
- Obesity-Induced Inflammation and Desmoplasia Promote Pancreatic Cancer Progression and Resistance to Chemotherapy
- (2016) J. Incio et al. Cancer Discovery
- NLRP3 Deficiency Reduces Macrophage Interleukin-10 Production and Enhances the Susceptibility to Doxorubicin-induced Cardiotoxicity
- (2016) Motoi Kobayashi et al. Scientific Reports
- Evaluation of Pancreatic Cancer Clinical Trials and Benchmarks for Clinically Meaningful Future Trials
- (2016) Lola Rahib et al. JAMA Oncology
- From bench to bedside a comprehensive review of pancreatic cancer immunotherapy
- (2016) Paul R. Kunk et al. Journal for ImmunoTherapy of Cancer
- Dual prognostic significance of tumour-associated macrophages in human pancreatic adenocarcinoma treated or untreated with chemotherapy
- (2015) Giuseppe Di Caro et al. GUT
- TLR9 ligation in pancreatic stellate cells promotes tumorigenesis
- (2015) Constantinos P. Zambirinis et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Role of NLRP3 Inflammasomes for Rhabdomyolysis-induced Acute Kidney Injury
- (2015) Takanori Komada et al. Scientific Reports
- TGF-β Blockade Reduces Mortality and Metabolic Changes in a Validated Murine Model of Pancreatic Cancer Cachexia
- (2015) Stephanie H. Greco et al. PLoS One
- Oncogenic Kras Activates a Hematopoietic-to-Epithelial IL-17 Signaling Axis in Preinvasive Pancreatic Neoplasia
- (2014) Florencia McAllister et al. CANCER CELL
- Cutting Edge: IL-1α Is a Crucial Danger Signal Triggering Acute Myocardial Inflammation during Myocardial Infarction
- (2014) Jérôme Lugrin et al. JOURNAL OF IMMUNOLOGY
- Nucleoside reverse transcriptase inhibitors possess intrinsic anti-inflammatory activity
- (2014) B. J. Fowler et al. SCIENCE
- Role of Immune Cells and Immune-Based Therapies in Pancreatitis and Pancreatic Ductal Adenocarcinoma
- (2013) Lei Zheng et al. GASTROENTEROLOGY
- The Epidemiology of Pancreatitis and Pancreatic Cancer
- (2013) Dhiraj Yadav et al. GASTROENTEROLOGY
- M2-polarized tumor-associated macrophages promoted epithelial–mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway
- (2013) Chao-Ying Liu et al. LABORATORY INVESTIGATION
- Oncogenic Kras-Induced GM-CSF Production Promotes the Development of Pancreatic Neoplasia
- (2012) Yuliya Pylayeva-Gupta et al. CANCER CELL
- Toll-like receptor 7 regulates pancreatic carcinogenesis in mice and humans
- (2012) Atsuo Ochi et al. JOURNAL OF CLINICAL INVESTIGATION
- MyD88 inhibition amplifies dendritic cell capacity to promote pancreatic carcinogenesis via Th2 cells
- (2012) Atsuo Ochi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis
- (2011) Eran Elinav et al. CELL
- Inflammasome-mediated suppression of inflammation-induced colorectal cancer progression is mediated by direct regulation of epithelial cell proliferation
- (2011) Bo Hu et al. CELL CYCLE
- TLR9 and the NLRP3 Inflammasome Link Acinar Cell Death With Inflammation in Acute Pancreatitis
- (2011) Rafaz Hoque et al. GASTROENTEROLOGY
- Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer
- (2011) Lucia De Monte et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
- (2011) Bolormaa Vandanmagsar et al. NATURE MEDICINE
- The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes
- (2011) Rebecca C. Coll et al. PLoS One
- The NLRP3 Inflammasome Protects against Loss of Epithelial Integrity and Mortality during Experimental Colitis
- (2010) Md. Hasan Zaki et al. IMMUNITY
- Control of Intestinal Homeostasis, Colitis, and Colitis-Associated Colorectal Cancer by the Inflammatory Caspases
- (2010) Jeremy Dupaul-Chicoine et al. IMMUNITY
- The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer
- (2010) Irving C. Allen et al. JOURNAL OF EXPERIMENTAL MEDICINE
- MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18
- (2010) Rosalba Salcedo et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Glyburide inhibits the Cryopyrin/Nalp3 inflammasome
- (2009) Mohamed Lamkanfi et al. JOURNAL OF CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started